In this study, we demonstrate that c-Maf directly regulates the expression of Sglt2 and Glut2 by binding to MARE sites and that c-Maf deletion attenuates STZ-induced diabetic nephropathy by improving diabetic conditions and reducing oxidative stress in the kidney. This evidence concerns the gene SLC5A2 and diabetic kidney disease.